Summary:
An investigational study is being conducted for the treatment of an involuntary movement disorder called Tardive Dyskinesia. The expected maximum duration of study participation for each participant is approximately 58 weeks.
Qualified participants must be 18-85 years of age and have schizophrenia or a schizoaffective disorder with Tardive Dyskinesia or mood disorder with Tardive Dyskinesia.
Qualified participants will receive study-related medical care and investigational medication at no cost and may be compensated for his/her time and inconvenience related to his/her participation in the study.